Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ANRS, Emerging Infectious Diseases
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults with the criteria for COVID-19 treatment within the French compassionate program (ATU/AAP)
Adults covered by the French social health coverage
Adults who signed the informed consent form
You may not be if
Patient participating in another biomedical research with an exclusion period ongoing at inclusion
Vulnerable patient (adults legally protected: under judicial protection, guardianship, or supervision, persons deprived of their liberty)
Pregnant or breastfeeding woman
Clareo Health | Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.
